Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
US11617750B2 · kind B2 · utility
0Cited by
22References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 2019 |
| Grant date | Apr 4, 2023 |
| Priority date | — |
| Expiry date | Sep 26, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various diseases, disorders or conditions related to HDAC6.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.